GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shilpa Medicare SHILPAMED.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

933.85

-0.90%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹15.39bn

FY2017FY2026

Net income

₹2.43bn

FY2017FY2026

Free cash flow

−₹754.0m

FY2017FY2026

Shareholders' equity

₹25.91bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹15.39bn₹12.86bn₹11.53bn₹10.43bn₹11.40bn₹9.00bn₹8.99bn₹7.01bn₹7.49bn₹7.30bn
Research and development₹612.4m₹483.7m₹309.6m₹491.0m₹550.6m₹338.1m₹369.0m₹213.0m₹272.8m₹240.8m
Operating income₹3.15bn₹2.04bn₹1.46bn−₹96.5m₹1.26bn₹2.19bn₹1.93bn₹1.17bn₹1.15bn₹1.35bn
Net income₹2.43bn₹782.9m₹318.7m−₹325.3m₹606.6m₹1.48bn₹1.56bn₹1.12bn₹1.05bn₹1.08bn
Diluted earnings per share12.454.001.63-1.883.488.739.576.886.466.60

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹37.06bn₹33.11bn₹30.93bn₹29.04bn₹28.75bn₹26.38bn₹19.89bn₹16.10bn₹14.99bn₹13.76bn
Cash and short-term investments₹451.8m₹585.6m₹302.3m₹221.9m₹338.3m₹1.65bn₹466.2m₹373.2m₹1.95bn₹3.25bn
Total liabilities₹11.14bn₹9.47bn₹12.93bn₹11.30bn₹10.64bn₹11.70bn₹6.68bn₹4.20bn₹4.19bn₹4.62bn
Debt₹6.60bn₹5.88bn₹9.37bn₹7.98bn₹6.83bn₹8.46bn₹3.92bn₹1.94bn₹1.91bn₹2.41bn
Shareholders' equity₹25.91bn₹23.72bn₹18.09bn₹17.83bn₹18.22bn₹14.79bn₹13.29bn₹11.98bn₹10.85bn₹9.16bn
Shares outstanding196m196m196m173m174m169m163m163m163m163m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹2.95bn₹1.32bn₹1.37bn₹2.26bn₹1.05bn₹469.3m₹1.24bn₹1.47bn₹449.2m₹374.8m
Capital spending−₹3.71bn−₹2.44bn−₹1.85bn−₹2.73bn−₹3.32bn−₹3.54bn−₹3.49bn−₹3.00bn−₹1.38bn−₹1.17bn
Free cash flow−₹754.0m−₹1.11bn−₹478.9m−₹463.7m−₹2.27bn−₹3.07bn−₹2.26bn−₹1.53bn−₹930.6m−₹796.4m
Dividends paid−₹97.8m——−₹95.5m−₹89.7m−₹89.7m−₹206.4m−₹206.4m−₹72.3m−₹53.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹4.66bn₹4.37bn₹4.10bn₹3.70bn₹3.21bn₹3.31bn₹3.19bn₹3.44bn
Operating income₹1.01bn₹890.9m₹839.4m₹784.6m₹627.2m₹479.6m₹518.8m₹577.2m
Net income₹1.01bn₹1.08bn₹445.8m₹440.7m₹468.9m₹145.1m₹317.8m₹179.4m
Diluted earnings per share5.165.512.282.252.400.741.620.92
Cash from operations———₹2.01bn—₹1.32bn—₹1.05bn
Capital spending———−₹1.63bn—−₹2.44bn—−₹1.19bn
Free cash flow———₹384.0m—−₹1.11bn—−₹140.0m
Total assets—₹37.06bn—₹34.95bn—₹33.11bn—₹31.17bn
Cash and short-term investments₹451.8m₹451.8m₹219.7m₹535.5m₹285.2m₹585.6m₹171.7m₹365.2m
Debt—₹6.59bn—₹5.93bn—₹5.88bn—₹4.91bn
Shareholders' equity₹25.91bn₹25.91bn₹24.39bn₹24.37bn₹23.64bn₹23.72bn₹23.19bn₹23.28bn

Financial ratios

Data as of 15 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin20.5%15.9%12.7%-0.9%11.0%24.3%
Net margin15.8%6.1%2.8%-3.1%5.3%16.4%
Return on equity9.4%3.3%1.8%-1.8%3.3%10.0%
Return on assets6.6%2.4%1.0%-1.1%2.1%5.6%
Free cash flow yield3.7%2.1%1.8%3.2%2.8%2.6%
Revenue growth19.6%11.6%10.5%-8.5%26.6%0.1%
Earnings growth210.8%145.6%-198.0%-153.6%-59.0%-5.4%
Current ratio1.31x1.46x1.26x0.98x1.45x1.52x
Debt to equity0.25x0.25x0.52x0.45x0.37x0.57x
Equity ratio69.9%71.7%58.5%61.4%63.4%56.1%
Interest coverage5.36x2.70x1.59x-0.16x3.07x10.00x
R&D as a share of sales4.0%3.8%2.7%4.7%4.8%3.8%
Buybacks as a share of market value0.0%0.0%-13.2%0.8%-2.9%-3.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.8%11.3%9.2%
Operating income—7.6%8.6%
Net income—10.5%8.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin18.4%13.1%14.2%15.8%
Net margin11.4%6.4%7.5%10.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings76.480.3250.1-87.440.030.623.520.429.746.8
Price to sales12.14.96.92.72.15.04.13.34.26.9

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 17 Sept 2025.

FY2026FY2023FY2022FY2020FY2018FY2017FY2016FY2015
Paid in the year0.500.550.551.050.350.300.5750.25
  • 2-for-1 split · 3 Oct 2025
  • 2-for-1 split · 6 Nov 2015
  • 3-for-2 split · 16 Jul 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.